B. Metzler Seel. Sohn & Co. AG / VRTX
B. Metzler Seel. Sohn & Co. AG’s Vertex Pharmaceuticals Inc Position
Does B. Metzler Seel. Sohn & Co. AG own Vertex Pharmaceuticals Inc (VRTX)? Yes — 511.0K shares worth $228M (+2.12% of its 13F portfolio) as of Q1 2026, down from 515.3K shares the prior filed quarter.
Position Value
$228M
Q1 2026
Shares
511.0K
% of Portfolio
+2.12%
Quarters Held
18
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 511.0K | $228M | +2.12% |
| Q4 2025 | 515.3K | $234M | +2.04% |
| Q3 2025 | 315.4K | $124M | +1.09% |
| Q2 2025 | 319.6K | $142M | +1.36% |
| Q1 2025 | 314.3K | $152M | +1.57% |
| Q4 2024 | 80.8K | $32M | +0.33% |
| Q3 2024 | 40.0K | $19M | +0.18% |
| Q2 2024 | 35.2K | $17M | +0.16% |
| Q1 2024 | 15.5K | $6M | +0.07% |
| Q4 2023 | 15.6K | $6M | +0.08% |
| Q3 2023 | 16.2K | $6M | +0.08% |
| Q2 2023 | 15.6K | $5M | +0.07% |
| Q1 2023 | 18.0K | $6M | +0.09% |
| Q4 2022 | 20.3K | $6M | +0.10% |
| Q3 2022 | 24.0K | $7M | +0.13% |
| Q2 2022 | 23.2K | $7M | +0.11% |
| Q1 2022 | 23.4K | $6M | +0.08% |
| Q4 2021 | 23.3K | $5M | +0.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See B. Metzler Seel. Sohn & Co. AG’s full portfolio or all institutional holders of VRTX.